OMEROS
Omeros is a Seattle-based commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system.
OMEROS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1994-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.omeros.com
Total Employee:
51+
Status:
Active
Contact:
2066765005
Total Funding:
965.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Apache
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Euthymics Bioscience
Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Oculis
Oculis is a clinical-stage, privately held, pharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2006-09-07 | Nura | Nura acquired by Omeros | N/A |
Investors List
CRG
CRG investment in Post-IPO Debt - Omeros
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Omeros
East West Bank
East West Bank investment in Post-IPO Debt - Omeros
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Omeros
East West Bank
East West Bank investment in Post-IPO Debt - Omeros
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Omeros
MidCap Financial
MidCap Financial investment in Post-IPO Debt - Omeros
National Institute of Mental Health
National Institute of Mental Health investment in Grant - Omeros
National Institute on Drug Abuse (NIDA)
National Institute on Drug Abuse (NIDA) investment in Grant - Omeros
Life Sciences Discovery Fund
Life Sciences Discovery Fund investment in Grant - Omeros
Newest Events participated
Official Site Inspections
http://www.omeros.com Semrush global rank: 2.18 M Semrush visits lastest month: 9.05 K
- Host name: 104.22.22.119
- IP address: 104.22.22.119
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago